VC-backed ProQR files for $75m IPO
ProQR Therapeutics, a Dutch biotech backed by Sofinnova Partners and Gilde Healthcare Partners, has filed with the US Securities and Exchange Commission (SEC) for a $75m IPO on the Nasdaq.
Sofinnova is currently one of ProQR's biggest shareholders with a 17.2% stake, while Gilde holds a 5.3% stake. The two firms backed the business earlier this year, according to Gilde's website.
ProQR has hired Leerink Partners and Deutsche Bank Securities as lead bookrunners for the flotation.
Founded in 2012 and headquartered in Leiden, ProQR develops drugs designed for the treatment of genetic disorders. It is currently working on a treatment for cystic fibrosis. The company employs 50 staff.
Daniel de Boer is the CEO of ProQR. Gilde partner Arthur Franken manages the firm's investment in the company. Managing partner Antoine Papiernik represents Sofinnova.
More on Benelux
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
EU FSR could impact PE fundraising with potential rise in ‘clean funds’
FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely
Letter from the editor: Unquote is moving to Mergermarket
Unquote Editor Harriet Matthews outlines Unquote.com's upcoming move to the Mergermarket platform and the new capabilities and intelligence that this brings to Unquote readers
Evoco expects portfolio acquisitions, assesses potential exits in 2H23
Switzerland-headquartered GP is currently deploying equity via its EUR 162m Evoco TSE III fund
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater